Two-year outcome of a randomized trial comparing second-generation drug-eluting stents using biodegradable or durable polymer.
暂无分享,去创建一个
[1] Hyun-Jae Kang,et al. Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis. , 2014, European heart journal.
[2] Mario Fusaro,et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis , 2013, BMJ.
[3] H. Suryapranata,et al. Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis , 2013, BMJ.
[4] T. Akasaka,et al. Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent: a randomized, controlled, noninferiority trial. , 2013, Journal of the American College of Cardiology.
[5] R. Perera,et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. , 2013, JAMA.
[6] A. Hill,et al. Hepatic resection for colorectal metastases. Value for risk scoring systems? , 2008, Annals of surgery.
[7] J. Donohue,et al. Hepatic Resection for Colorectal Metastases: Value for Risk Scoring Systems? , 2007, Annals of surgery.
[8] A. Lacy,et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] Bruce D Minsky,et al. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.